EPCAM and neoplasm: The particles were then conjugated with anti-EpCAM antibodies: Figure 2c depicts the nanoparticles, while Figure 2d shows aggregates of these nanoparticles on HT-29 tumor cells, both analyses performed by transmission and scanning electron microscopy, respectively.